Berlin Cures' failed Long COVID clinical trial yields lessons on study design
BC 007, a German infusion drug that targets
autoantibodies, is heading for new study. Graphic showing the top of Berlin's
TV Tower, edited to look ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.